HOME >> BIOLOGY >> NEWS
New study in JAMA details trends in diagnosis, treatment of brain tumors

CHARLOTTESVILLE, Va., Feb. 2, 2005 -- A two year study involving over 560 patients with the newly-diagnosed malignant brain tumors shows that patterns of care are varied and there is a need for new, detailed clinical guidelines for management of brain tumors. The study is published in the Feb. 2, 2005 issue of the Journal of the American Medical Association (JAMA) found on the web at www.jama.ama-assn.org.

"We have a long way to go because we still do not have a reliable way of controlling these malignant tumors," said study co-author Dr. Edward R. Laws, Jr., professor of neurological surgery, internal medicine and pediatrics at the University of Virginia Health System. "Physicians and other caregivers do fairly well treating these tumors, but this important study helps us see where we might do better." The average life expectancy for patients with malignant brain tumors is a little over one year, unchanged since the 1960's, Laws said.

The study found that there are common practice patterns that follow published medical findings, such as the use of radiation therapy, magnetic resonance imaging (MRI) or surgery on brain tumor patients. Over 75 percent of patients underwent such procedures (92 percent in the case of MRI, 87 percent in the case of postoperative radiation therapy).

But, the study discovered that some practice patterns contradict published guidelines. Over 80 percent of the patients received anti-epileptic drugs, where there is little value for patients who do not have epileptic seizures and significant side effects. The infrequent use of chemotherapy may also conflict with published literature. Only 54 percent of patients received chemotherapy, which has been found to correlate with increased survival, though modest.

One of the most surprising findings was the infrequent use of anti-depressant medications (8 percent) for patients with symptoms of depression. "The
'"/>

Contact: Bob Beard
reb8e@virginia.edu
434-982-4490
University of Virginia Health System
2-Feb-2005


Page: 1 2

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... ... Phase II contract awarded by the Joint Science & Technology Office—Chemical and Biological ... is to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device ... The study reported that the Neoasis™ device attenuated the alarm sounds from patient ...
(Date:7/10/2020)... ... 2020 , ... Today CJ BIO announced the first in a series of ... taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a ... July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has announced ... Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the ... awards program, highlighting outstanding examples of how technology innovations and strategic initiatives can ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... that the launch of a new clinical diagnostics immuno-oncology service, TissueInsight ... microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... cancer, today announced the company has entered a license agreement with Roswell Park ... Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel medical ...
(Date:6/23/2020)... ORLANDO, Fla. (PRWEB) , ... June 23, 2020 ... ... proximity enabled solutions in complex indoor environments, announced today that Derek Fournier has ... the role of Chairman of the Board, effective immediately. , “DeCurtis Corporation ...
Breaking Biology Technology:
Cached News: